Intriguing thought....regarding buying at or below $.06 (and be considered very cheap). I would speculate that Fair value today is at least $75mm-$100mm or $.18-$.30 range.
A multi platform drug with MANF and fast advancing Alzheimer's diagnostic product with LymPro (with a blossoming relationship with Becton Dickinson in play); include MANF Orphan indications, other Diagnostic products such as NuroPro (and others), patents and a world class Advisory team (Amgen, Merck, Bayer and Bristol Myers backgrounds).
GLTA!!!
News 
Market Data 
Discover 
